Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
The transaction is expected to close in Q2 FY 2026
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
If approved, linerixibat could address high unmet medical need of patients living with cholestatic pruritus (relentless itch) and related sleep interference
The newly launched protocol will accelerate the clinical development of stenoparib and its drug-specific Drug Response Predictor (DRP) companion diagnostic (CDx) toward potential FDA approval
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Subscribe To Our Newsletter & Stay Updated
